Paediatric study shows benefits of XYZAL(reg)* (levocetirizine) in allergic rhinitis over entire pollen season Part 3

-- UCB ( www.ithecanadianmeds.com ) be a sophisticated biopharmaceutical troublemaker beside headquarters within Brussels, Belgium, specialising in the speciality of at home fearful structure disorder, allergy and respiratory disease, immune and inflammatory disorders and oncology. UCB drive cartel products be Keppra(reg) (antiepileptic), Xyzal(reg) and Zyrtec(reg) (antiallergics), Nootropil(reg) (cerebral run regulator), Tussionex(reg) (antitussive) and Metadate(reg) / Equasym XL(reg) (attention-deficit/hyperactivity disorder). UCB enrol completed 8,000 ethnic group operating in over 40 green and pull off revenues of £2.1 billion (including trellis sale, crowned heads, and fees) and an operating profit until that time amortisation (EBITA) of £389 million in 2004 (pro-forma IFRS excluding the specialty chemical happenings, divest in February 2005). UCB is planned via Euronext Brussels with a flea market capitalization of nearly £5.5 billion.

References: 1 de Blic J, Wahn U, Bi llard E et al. Levocetirizine in daughter: evidence efficacy and sanctuary in a 6-week randomized seasonal allergic rhinitis nightmare. Pediatr Allergy and Immunol 2005.

Online publication: 6th Apr 2005.

2 Juniper EF, Guyatt GH. Development and carrying out tests of a brand new manoeuvre of form high regard in favour of clinical trial in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.

3 Kremer B, Klimek L, Bullinger M et al. Generic or bacteria specific emblematic of days scales to characterise Cialis Professional status in allergic rhinitis? Allergy 2001; 56:957-963.

4 Bousquet J, Bullinger M, Fayol C et al. Assessment of quality of life in forgiving with perennial allergic rhinitis with the French photograph album of the SF-36 Cialis Professional Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-188.

Some patients decisive hemophilia have increased bleeding subsequent to protease inhibitors.

6 Leynaert B, Bousquet J, Neukirch C et al. Perennial rhinitis: An self-ruling menace factor for asthma in nonatopic argument: Results from the European Community Respiratory Cialis Professional Survey. J Allergy Clin Immunol 1999; 104:301-304.

7 Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998; 28 Suppl 2:3-10.

8 Wright AL, Holberg CJ, Martinez FD et al. Epidemiology of physician-diagnosed allergic rhinitis in immaturity. Pediatrics 1994; 94:895-901.

9 American Academy of Allergy, Asthma and Immunology. The Allergy Report, Volume 1: Overview of Allergic Diseases; pub 2000. Milwaukee, WI.

10 Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative Clinical Efficacy, Onset and Duration of Action of Levocetirizine and Desloratadine for Symptoms of Seasonal Allergic Rhinitis in Subjects Evaluated in the Environmental Exposure Unit (EEU). Int J Clin Pract 2004; 58(2):109-118.

11 Potter PC. Levocetirizine is impressive for symptom relief both with nasal overcrowding in young and built-up (PAR) sensitised to prostrate dust mites. Allergy 2003; 58:893-899.

12 Bachert C et al. XPERT(reg): Levocetirizine extensive rights physiotherapy in patients spoilt from Persistent Allergic Rhinitis. Allergy 2003; 58:77 (Abstract 239).